Icure Pharmaceutical Incorporation Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Icure Pharmaceutical Incorporation.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Personal Products earnings growth | 9.8% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Icure Pharmaceutical Incorporation (KOSDAQ:175250) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
Sep 04
Is Icure Pharmaceutical Incorporation (KOSDAQ:175250) A Risky Investment?
Aug 28What Icure Pharmaceutical Incorporation's (KOSDAQ:175250) 27% Share Price Gain Is Not Telling You
Jul 21Icure Pharmaceutical Incorporation (KOSDAQ:175250) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
May 31Is Icure Pharmaceutical Incorporation (KOSDAQ:175250) Using Debt In A Risky Way?
May 27Some Shareholders Feeling Restless Over Icure Pharmaceutical Incorporation's (KOSDAQ:175250) P/S Ratio
Mar 07We Think Icure Pharmaceutical Incorporation (KOSDAQ:175250) Has A Fair Chunk Of Debt
Dec 25
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Icure Pharmaceutical Incorporation has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 59,844 | -23,888 | -15,976 | -14,683 | N/A |
| 3/31/2024 | 57,108 | -28,939 | -15,558 | -13,262 | N/A |
| 12/31/2023 | 56,806 | -31,420 | -16,146 | -13,519 | N/A |
| 9/30/2023 | 59,572 | -34,678 | -17,482 | -13,708 | N/A |
| 6/30/2023 | 61,356 | -38,135 | -15,420 | -11,041 | N/A |
| 3/31/2023 | 61,369 | -42,040 | -18,710 | -14,365 | N/A |
| 12/31/2022 | 59,367 | -41,766 | -17,247 | -11,282 | N/A |
| 9/30/2022 | 59,239 | -38,067 | -16,120 | -10,794 | N/A |
| 6/30/2022 | 56,894 | -41,963 | -26,112 | -19,955 | N/A |
| 3/31/2022 | 60,940 | -40,690 | -28,023 | -20,681 | N/A |
| 12/31/2021 | 64,283 | -38,167 | -32,935 | -26,228 | N/A |
| 9/30/2021 | 70,224 | -29,807 | -39,490 | -29,113 | N/A |
| 6/30/2021 | 76,826 | -20,638 | -38,630 | -21,917 | N/A |
| 3/31/2021 | 83,550 | -15,083 | -38,403 | -15,625 | N/A |
| 12/31/2020 | 90,144 | -12,614 | -39,667 | -12,403 | N/A |
| 9/30/2020 | 87,504 | -19,684 | -42,909 | -9,652 | N/A |
| 6/30/2020 | 86,905 | -15,143 | -42,603 | -6,023 | N/A |
| 3/31/2020 | 77,452 | -9,153 | -44,230 | -9,299 | N/A |
| 12/31/2019 | 60,922 | -8,751 | -72,489 | -5,943 | N/A |
| 9/30/2019 | 49,822 | 4,978 | -65,096 | -6,898 | N/A |
| 6/30/2019 | 37,867 | -1,848 | -59,351 | -9,900 | N/A |
| 3/31/2019 | 31,479 | -11,411 | -52,251 | -8,319 | N/A |
| 12/31/2018 | 33,320 | -7,885 | -19,765 | -7,304 | N/A |
| 9/30/2018 | 36,227 | -6,647 | -20,131 | -5,321 | N/A |
| 6/30/2018 | 40,747 | -3,916 | -15,991 | -658 | N/A |
| 3/31/2018 | 40,230 | 2,704 | N/A | 2,094 | N/A |
| 12/31/2017 | 39,796 | 538 | N/A | 1,119 | N/A |
| 9/30/2017 | 37,952 | -813 | N/A | 500 | N/A |
| 6/30/2017 | 32,964 | -1,231 | N/A | -2,880 | N/A |
| 3/31/2017 | 30,189 | -2,889 | N/A | -4,390 | N/A |
| 12/31/2016 | 27,279 | -3,243 | N/A | -4,879 | N/A |
| 9/30/2016 | 23,914 | -3,367 | N/A | -4,071 | N/A |
| 6/30/2016 | 19,517 | -3,811 | N/A | -3,498 | N/A |
| 3/31/2016 | 17,967 | -3,301 | N/A | -2,057 | N/A |
| 12/31/2015 | 18,673 | -2,878 | N/A | -204 | N/A |
| 12/31/2014 | 14,930 | 958 | N/A | 542 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A175250's forecast earnings growth is above the savings rate (2.7%).
Earnings vs Market: Insufficient data to determine if A175250's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A175250's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A175250's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A175250's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A175250's Return on Equity is forecast to be high in 3 years time